Research hints at underlying cause for Alzheimer's drug trial failures

October 3rd, 2016 | Posted by admin in Uncategorized

A certain form of immunotherapy targeted to Alzheimer's patients may be ineffective when that patient also has Vascular Cognitive Impairment and Dementia, report scientists. While these drugs showed promise in animal studies, clinical trials have failed to show similar benefits in human patients.
Source: Care Giving Science Daily

You can follow any responses to this entry through the RSS 2.0 You can leave a response, or trackback.

Leave a Reply

Your email address will not be published. Required fields are marked *